Editor in Chief

Overview

BMJ seeks to appoint an inaugural Editor-in-Chief for its newest open access publication, BMJ Oncology. 

The ideal candidate is an active physician-researcher in clinical oncology. Specialists in any field of oncology are welcome to apply.

The Editor-in-Chief will act as an ambassador, upholding the highest ethical standards and editorial policies, as well as actively promoting and developing the journal. Applicants should have international stature in the field of oncology, a distinguished publication record, and editorial experience. The successful candidate will recognize the need to engage the journal’s audiences at all levels and develop its content and global reach. Because BMJ Oncology is a new publication, the Editor-in-Chief’s role will include establishing a vision that sets the journal’s international reputation and profile and providing engaging and informed content that has a tangible impact on the quality of patient care.

Applicants should have an MD and PhD or equivalent and should be able to demonstrate their impact in the field. The ideal candidate will have a proven commitment to education and academic excellence. 

This is an independent contractor position, and the initial term of office is 5 years. The Editor-in-Chief has responsibility for the editorial strategy and content of BMJ Oncology, with support from their appointed editorial team and BMJ. Editorial training and technical support will be provided, together with strategic guidance. An annual stipend and other benefits are provided, as well as experienced editorial office support. The Editor should expect to spend approximately 10-15 hours per week in total for journal-related activities, but this will depend on the structure of the editorial team.

To be considered for the role, please send your CV and a covering letter outlining your interest and experience and your editorial vision for the development of this new publication. Applications should be sent to Kathleen Lyons, Publisher, at klyons@bmj.com. International and joint applications are welcome. Interviews will be held via video conference.

Application deadline: October 15, 2021

About BMJ Oncology

BMJ Oncology is a new online only, open access publication from BMJ, set to launch in the first quarter of 2022. It will publish high quality peer-reviewed original research covering the full spectrum of clinical and basic science research in oncology. BMJ Oncology aims to provide rapid publication through a continuous publication model. All submitted content is subject to rigorous peer review prior to publication and published work is free to read, download, and share under the open access model.

Responsibilities

• Provide the highest possible quality content for BMJ Oncology readers
• Build a supportive team of highly qualified international colleagues to serve as members of the editorial team
• Maintain and ensure the integrity of the review process and publishing ethics, providing guidance to authors and reviewers as appropriate
• Develop procedures for effective triage and review of articles to ensure timely and excellent support is maintained for authors and reviewers

As Editor-in-Chief of BMJ Oncology, you will benefit from the following:

• Annual honorarium
• Attendance at a Medical Editors’ training course
• Networking events with other BMJ Journal Editors
• Full training and support, from publishing processes to social media
• The chance to shape the field and play a role in the development of the specialty
• Opportunities to interact with scientists conducting research around the world

About BMJ

BMJ is a global healthcare knowledge provider with a vision for a healthier world. We share knowledge and expertise to improve healthcare outcomes. Along with our renowned flagship title, The BMJ, we offer over 70 specialty journals and a world leading collection of digital professional development resources. Our expertise extends from publishing and medical education to clinical decision support and events to enhance day-to-day decision-making and healthcare delivery.